Multiple studies have demonstrated that decreased ERO1α expression impairs angiogenesis by decreasing VEGF-A secretion, suggesting that ERO1αcan play a role in the angiogenesis process critical for cancer progression and metastasis. The gene discussed is ERO1A; the disease is cancer.